• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞外囊泡:新兴的抗癌药物和先进的癌症治疗功能化平台。

Extracellular vesicles: emerging anti-cancer drugs and advanced functionalization platforms for cancer therapy.

机构信息

Department of Clinical Laboratory, The First Affiliated Hospital of UST C, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, P.R. China.

Anhui Provincial Children's Hospital, Hefei, Anhui, P.R. China.

出版信息

Drug Deliv. 2022 Dec;29(1):2513-2538. doi: 10.1080/10717544.2022.2104404.

DOI:10.1080/10717544.2022.2104404
PMID:35915054
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9347476/
Abstract

Increasing evidences show that unmodified extracellular vesicles (EVs) derived from various cells can effectively inhibit the malignant progression of different types of tumors by delivering the bioactive molecules. Therefore, EVs are expected to be developed as emerging anticancer drugs. Meanwhile, unmodified EVs as an advanced and promising nanocarrier that is frequently used in targeted delivery therapeutic cargos and personalized reagents for the treatment and diagnosis of cancer. To improve the efficacy of EV-based treatments, researchers are trying to engineering EVs as an emerging nanomedicine translational therapy platform through biological, physical and chemical approaches, which can be broaden and altered to enhance their therapeutic capability. EVs loaded with therapeutic components such as tumor suppressor drugs, siRNAs, proteins, peptides, and conjugates exhibit significantly enhanced anti-tumor effects. Moreover, the design and preparation of tumor-targeted modified EVs greatly enhance the specificity and effectiveness of tumor therapy, and these strategies are expected to become novel ideas for tumor precision medicine. This review will focus on reviewing the latest research progress of functionalized EVs, clarifying the superior biological functions and powerful therapeutic potential of EVs, for researchers to explore new design concepts based on EVs and build next-generation nanomedicine therapeutic platforms.

摘要

越来越多的证据表明,源自各种细胞的未修饰细胞外囊泡(EVs)可以通过传递生物活性分子有效抑制不同类型肿瘤的恶性进展。因此,EVs 有望被开发为新兴的抗癌药物。同时,未修饰的 EVs 作为一种先进且有前途的纳米载体,常被用于靶向递送治疗 cargos 和个性化试剂,用于癌症的治疗和诊断。为了提高基于 EV 的治疗效果,研究人员正试图通过生物、物理和化学方法将 EV 工程化为一种新兴的纳米医学转化治疗平台,这可以拓宽和改变以增强其治疗能力。负载有治疗成分(如肿瘤抑制药物、siRNAs、蛋白质、肽和缀合物)的 EVs 表现出显著增强的抗肿瘤效果。此外,肿瘤靶向修饰 EVs 的设计和制备大大提高了肿瘤治疗的特异性和有效性,这些策略有望成为肿瘤精准医学的新思想。本文将重点综述功能化 EVs 的最新研究进展,阐明 EVs 的优越生物学功能和强大的治疗潜力,为研究人员探索基于 EVs 的新设计理念和构建下一代纳米医学治疗平台提供参考。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/400d/9347476/d3aec82c0c55/IDRD_A_2104404_F0007_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/400d/9347476/195b4c55b087/IDRD_A_2104404_F0001_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/400d/9347476/5c90267350e2/IDRD_A_2104404_F0002_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/400d/9347476/1ff1ca5a7d7e/IDRD_A_2104404_F0003_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/400d/9347476/cb0760df3a31/IDRD_A_2104404_F0004_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/400d/9347476/2e302fc0de36/IDRD_A_2104404_F0005_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/400d/9347476/39b0a5cc797e/IDRD_A_2104404_F0006_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/400d/9347476/d3aec82c0c55/IDRD_A_2104404_F0007_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/400d/9347476/195b4c55b087/IDRD_A_2104404_F0001_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/400d/9347476/5c90267350e2/IDRD_A_2104404_F0002_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/400d/9347476/1ff1ca5a7d7e/IDRD_A_2104404_F0003_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/400d/9347476/cb0760df3a31/IDRD_A_2104404_F0004_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/400d/9347476/2e302fc0de36/IDRD_A_2104404_F0005_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/400d/9347476/39b0a5cc797e/IDRD_A_2104404_F0006_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/400d/9347476/d3aec82c0c55/IDRD_A_2104404_F0007_C.jpg

相似文献

1
Extracellular vesicles: emerging anti-cancer drugs and advanced functionalization platforms for cancer therapy.细胞外囊泡:新兴的抗癌药物和先进的癌症治疗功能化平台。
Drug Deliv. 2022 Dec;29(1):2513-2538. doi: 10.1080/10717544.2022.2104404.
2
Extracellular vesicles: A bright star of nanomedicine.细胞外囊泡:纳米医学的一颗璀璨明星。
Biomaterials. 2021 Feb;269:120467. doi: 10.1016/j.biomaterials.2020.120467. Epub 2020 Nov 6.
3
Anticancer Therapy Targeting Cancer-Derived Extracellular Vesicles.靶向肿瘤来源细胞外囊泡的抗癌治疗。
ACS Nano. 2024 Mar 5;18(9):6748-6765. doi: 10.1021/acsnano.3c06462. Epub 2024 Feb 23.
4
Engineered Extracellular Vesicles as a Targeted Delivery Platform for Precision Therapy.工程细胞外囊泡作为精准治疗的靶向递送平台。
Tissue Eng Regen Med. 2023 Apr;20(2):157-175. doi: 10.1007/s13770-022-00503-y. Epub 2023 Jan 13.
5
Emerging Significance and Therapeutic Potential of Extracellular vesicles.细胞外囊泡的新兴意义和治疗潜力。
Int J Biol Sci. 2021 Jun 16;17(10):2476-2486. doi: 10.7150/ijbs.59296. eCollection 2021.
6
Application of engineered extracellular vesicles for targeted tumor therapy.工程细胞外囊泡在靶向肿瘤治疗中的应用。
J Biomed Sci. 2022 Feb 21;29(1):14. doi: 10.1186/s12929-022-00798-y.
7
Engineered Extracellular Vesicles for Cancer Therapy.工程细胞外囊泡用于癌症治疗。
Adv Mater. 2021 Apr;33(14):e2005709. doi: 10.1002/adma.202005709. Epub 2021 Feb 28.
8
Engineered extracellular vesicles as intelligent nanosystems for next-generation nanomedicine.工程细胞外囊泡作为新一代纳米医学的智能纳米系统。
Nanoscale Horiz. 2022 Jun 27;7(7):682-714. doi: 10.1039/d2nh00070a.
9
Surface-engineered extracellular vesicles for targeted delivery of therapeutic RNAs and peptides for cancer therapy.表面工程化的细胞外囊泡用于靶向递送达治疗性 RNA 和肽用于癌症治疗。
Theranostics. 2022 Apr 11;12(7):3288-3315. doi: 10.7150/thno.68667. eCollection 2022.
10
Extracellular vesicles as natural therapeutic agents and innate drug delivery systems for cancer treatment: Recent advances, current obstacles, and challenges for clinical translation.细胞外囊泡作为癌症治疗的天然治疗剂和固有药物递送系统:最新进展、当前障碍及临床转化面临的挑战
Semin Cancer Biol. 2022 May;80:340-355. doi: 10.1016/j.semcancer.2020.08.007. Epub 2020 Sep 22.

引用本文的文献

1
New Challenges and Opportunities: Extracellular Vesicles in Biological and Biochemical Processes.新挑战与机遇:生物与生化过程中的细胞外囊泡
Int J Mol Sci. 2025 Apr 4;26(7):3395. doi: 10.3390/ijms26073395.
2
MSC-derived extracellular vesicles: Precision miRNA delivery for overcoming cancer therapy resistance.间充质干细胞衍生的细胞外囊泡:用于克服癌症治疗耐药性的精准miRNA递送
Regen Ther. 2025 Apr 1;29:303-318. doi: 10.1016/j.reth.2025.03.006. eCollection 2025 Jun.
3
Exosome-based miRNA delivery: Transforming cancer treatment with mesenchymal stem cells.

本文引用的文献

1
A Microfluidics-Based Scalable Approach to Generate Extracellular Vesicles with Enhanced Therapeutic MicroRNA Loading for Intranasal Delivery to Mouse Glioblastomas.基于微流控的可扩展方法,用于生成具有增强的治疗性 microRNA 负载的细胞外囊泡,用于经鼻递送至小鼠脑胶质瘤。
ACS Nano. 2021 Nov 23;15(11):18327-18346. doi: 10.1021/acsnano.1c07587. Epub 2021 Nov 1.
2
M1 macrophage exosomes engineered to foster M1 polarization and target the IL-4 receptor inhibit tumor growth by reprogramming tumor-associated macrophages into M1-like macrophages.经工程改造促进 M1 极化并靶向白细胞介素 4 受体的 M1 巨噬细胞外泌体通过将肿瘤相关巨噬细胞重编程为 M1 样巨噬细胞来抑制肿瘤生长。
Biomaterials. 2021 Nov;278:121137. doi: 10.1016/j.biomaterials.2021.121137. Epub 2021 Sep 17.
3
基于外泌体的微小RNA递送:用间充质干细胞改变癌症治疗
Regen Ther. 2025 Feb 13;28:558-572. doi: 10.1016/j.reth.2025.01.019. eCollection 2025 Mar.
4
Harnessing tomato-derived small extracellular vesicles as drug delivery system for cancer therapy.利用源自番茄的小细胞外囊泡作为癌症治疗的药物递送系统。
Future Sci OA. 2025 Dec;11(1):2461956. doi: 10.1080/20565623.2025.2461956. Epub 2025 Feb 7.
5
Extracellular vesicles: from intracellular trafficking molecules to fully fortified delivery vehicles for cancer therapeutics.细胞外囊泡:从细胞内运输分子到用于癌症治疗的全面强化递送载体。
Nanoscale Adv. 2025 Jan 15;7(4):934-962. doi: 10.1039/d4na00393d. eCollection 2025 Feb 11.
6
The Potential for Extracellular Vesicles in Nanomedicine: A Review of Recent Advancements and Challenges Ahead.纳米医学中细胞外囊泡的潜力:近期进展与未来挑战综述
Adv Biol (Weinh). 2024 Dec 31:e2400623. doi: 10.1002/adbi.202400623.
7
Highly Efficient Delivery of Novel MiR-13896 by Human Umbilical Cord Mesenchymal Stem Cell-Derived Small Extracellular Vesicles Inhibits Gastric Cancer Progression by Targeting ATG2A-Mediated Autophagy.人脐带间充质干细胞来源的小细胞外囊泡高效递送新型MiR-13896通过靶向ATG2A介导的自噬抑制胃癌进展
Biomater Res. 2024 Dec 18;28:0119. doi: 10.34133/bmr.0119. eCollection 2024.
8
Extracellular Vesicles and Their Applications in Tumor Diagnostics and Immunotherapy.细胞外囊泡及其在肿瘤诊断和免疫治疗中的应用。
Cells. 2024 Dec 9;13(23):2031. doi: 10.3390/cells13232031.
9
Dual roles of extracellular vesicles in acute lymphoblastic leukemia: implications for disease progression and theranostic strategies.细胞外囊泡在急性淋巴细胞白血病中的双重作用:对疾病进展和治疗策略的影响。
Med Oncol. 2024 Nov 22;42(1):11. doi: 10.1007/s12032-024-02547-7.
10
Unlocking the Secrets of Extracellular Vesicles: Orchestrating Tumor Microenvironment Dynamics in Metastasis, Drug Resistance, and Immune Evasion.揭开细胞外囊泡的秘密:调控肿瘤微环境在转移、耐药和免疫逃逸中的动态变化
J Cancer. 2024 Oct 14;15(19):6383-6415. doi: 10.7150/jca.98426. eCollection 2024.
Engineered exosome-like nanovesicles suppress tumor growth by reprogramming tumor microenvironment and promoting tumor ferroptosis.工程化的外泌体样纳米囊泡通过重编程肿瘤微环境和促进肿瘤铁死亡来抑制肿瘤生长。
Acta Biomater. 2021 Nov;135:567-581. doi: 10.1016/j.actbio.2021.09.003. Epub 2021 Sep 8.
4
Apoptotic Extracellular Vesicles Ameliorate Multiple Myeloma by Restoring Fas-Mediated Apoptosis.凋亡细胞外囊泡通过恢复 Fas 介导的细胞凋亡来改善多发性骨髓瘤。
ACS Nano. 2021 Sep 28;15(9):14360-14372. doi: 10.1021/acsnano.1c03517. Epub 2021 Sep 10.
5
Therapeutic roles of mesenchymal stem cell-derived extracellular vesicles in cancer.间充质干细胞衍生的细胞外囊泡在癌症中的治疗作用。
J Hematol Oncol. 2021 Sep 3;14(1):136. doi: 10.1186/s13045-021-01141-y.
6
Engineering Exosomes Endowed with Targeted Delivery of Triptolide for Malignant Melanoma Therapy.工程化外泌体靶向递送达泊苷用于恶性黑素瘤治疗。
ACS Appl Mater Interfaces. 2021 Sep 15;13(36):42411-42428. doi: 10.1021/acsami.1c10325. Epub 2021 Aug 31.
7
Engineered exosomes for co-delivery of PGM5-AS1 and oxaliplatin to reverse drug resistance in colon cancer.用于共同递送PGM5-AS1和奥沙利铂以逆转结肠癌耐药性的工程化外泌体。
J Cell Physiol. 2022 Jan;237(1):911-933. doi: 10.1002/jcp.30566. Epub 2021 Aug 31.
8
Ginseng-derived nanoparticles potentiate immune checkpoint antibody efficacy by reprogramming the cold tumor microenvironment.人参衍生纳米颗粒通过重编程冷肿瘤微环境增强免疫检查点抗体疗效。
Mol Ther. 2022 Jan 5;30(1):327-340. doi: 10.1016/j.ymthe.2021.08.028. Epub 2021 Aug 25.
9
Sequentially Triggered Bacterial Outer Membrane Vesicles for Macrophage Metabolism Modulation and Tumor Metastasis Suppression.顺序触发的细菌外膜囊泡用于调节巨噬细胞代谢和抑制肿瘤转移。
ACS Nano. 2021 Aug 24;15(8):13826-13838. doi: 10.1021/acsnano.1c05613. Epub 2021 Aug 12.
10
Designer exosomes for targeted and efficient ferroptosis induction in cancer via chemo-photodynamic therapy.通过化疗-光动力疗法设计用于靶向和有效诱导癌症中铁死亡的外泌体。
Theranostics. 2021 Jul 13;11(17):8185-8196. doi: 10.7150/thno.59121. eCollection 2021.